2013
DOI: 10.1016/j.atherosclerosis.2013.06.016
|View full text |Cite
|
Sign up to set email alerts
|

Ezetimibe decreases serum oxidized cholesterol without impairing bile acid synthesis in Japanese hypercholesterolemic patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 15 publications
0
7
0
Order By: Relevance
“…Eleven studies met the inclusion criteria (Table 3). Three studies were performed in patients with Familial Combined Hyperlipidemia (FCH) [54,55,56], one study in patients with Familial Hypercholesterolemia (FH) [57], and four studies included patients with FCH, FH or another (non-FH) form of hypercholesterolemia [58,59,60,61]. Patients with hypercholesterolemia other than FCH of FH were evaluated in three studies [62,63,64].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Eleven studies met the inclusion criteria (Table 3). Three studies were performed in patients with Familial Combined Hyperlipidemia (FCH) [54,55,56], one study in patients with Familial Hypercholesterolemia (FH) [57], and four studies included patients with FCH, FH or another (non-FH) form of hypercholesterolemia [58,59,60,61]. Patients with hypercholesterolemia other than FCH of FH were evaluated in three studies [62,63,64].…”
Section: Resultsmentioning
confidence: 99%
“…In patients diagnosed with hypercholesterolemia other than FCH or FH, at least one of the cholesterol absorption markers increased in three comparisons [58,60,61], was comparable in two comparisons [64], and was not tested or measured in three comparisons [59,62,63]. One study reported higher cholesterol absorption in subjects diagnosed with heterogeneous autosomal dominant hypercholesterolemia compared to normolipidemic control subjects [61].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Beneficial effects of ezetimibe have been demonstrated not only on serum oxidized cholesterols 35 or stable long-term reduction in LDL-C, 36 but also on clinical outcome following elective vascular surgery 37 or AMI. 38 Conversely, combined therapy of ezetimibe and simvastatin showed no difference in intima-media thickness as compared with simvastatin alone; 39 moreover, the use of ezetimibe led to a paradoxical increase in the carotid intima-media thickness in association with greater reduction in LDL-C. 40, 41 The present study was not designed to evaluate the efficacy of ezetimibe, but no disadvantage was observed in patients requiring ezetimibe to control high LDL-C under the initial statin therapy.…”
Section: Discussionmentioning
confidence: 99%
“…101 Moreover, the level of 27-OHC has been reported to be 5 times lower than that of desmosterol in human plasma. 117,118 The physiological relevance of different sterols thus still seems to be not completely clear and needs further evaluation. 3.1.5 Neoruscogenin.…”
Section: A-hydroxycholesterolmentioning
confidence: 99%